Please login to the form below

Not currently logged in
Email:
Password:

Biogen appoints executive VP, corporate development

Daniel Karp will also become a member of the executive committee

Daniel KarpBiogen has appointed Daniel Karp as its executive vice president, corporate development effective 11 June.

Karp’s new role will see him lead the newly created corporate development function, which will include corporate and business development and corporate strategy.

He will also become a member of the executive committee and will report directly to chief executive officer Michel Vounatsos, who said: “We are very pleased to welcome Daniel to Biogen as we continue our journey as pioneers in neuroscience.

“Daniel's solid experience from Pfizer combined with his scientific and business education will serve him well in this exciting position as we aim to further build our pipeline and portfolio to tackle unmet needs in neurological diseases.”

Daniel joins Biogen from Pfizer where he most recently was Vice President, Worldwide Business Development and head of business development for R&D.  In that role, he led a global team responsible for early science transactions, partnerships and acquisitions across Pfizer's research portfolio.

He said: “It's a privilege to join Biogen, a true leader in neuroscience," Karp said.  "I'm excited to work with Biogen's innovative and talented team as we work to expand the company's portfolio of therapies for people living with serious neurodegenerative diseases.”

11th June 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics